ARTMS Inc. and Isotopia Molecular Imaging
ARTMS and Isotopia Molecular Imaging Announce Successful Multi-Curie Labeling of PSMA-11 With Cyclotron Produced 68Ga Utilizing the QUANTM Irradiation System™ and Solid Targets
Wednesday, January 20, 2021 11:00AM IST (5:30AM GMT)
ARTMS Inc. (ARTMS) and
Isotopia Molecular
Imaging (Isotopia) are pleased to announce the successful radiolabeling of Isotopia’s prostate cancer imaging kit product, PSMA-11, with over 2 Ci of cyclotron-produced Gallium-68 (
68Ga) using ARTMS’ proprietary Quantum Irradiation System™ (QIS™) solid target system.
The specially designed Prostate-Specific Membrane Antigen (PSMA) kit for the preparation of
68Ga-PSMA-11 (a radiopharmaceutical targeting PSMA for the imaging of prostate cancer using Positron Emission Tomography (PET)) was radiolabeled with high activity cyclotron produced